Why the study?
Do noninvasive peripheral endothelial function tests (FMD and RH-PAT) predict cardiovascular events?
Do noninvasive peripheral endothelial function tests (FMD and RH-PAT) predict cardiovascular events?
Noninvasive peripheral endothelial function tests (FMD and RH-PAT) are significant predictors of cardiovascular events with similar prognostic value.
Answers are grounded in this paper and cite their sources.
FMD and RH-PAT may refine CV risk stratification; confirms comparable prognostic value across studies.
Noninvasive peripheral endothelial function tests, FMD and RH-PAT, significantly predicted cardiovascular events, with similar prognostic magnitude. Further research is required to determine whether the prognostic values of these 2 methods are independent of each other and whether an endothelial function-guided strategy can provide benefit in improving cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Matsuzawa et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: